134 related articles for article (PubMed ID: 3450479)
1. Antitumour effects of tumour necrosis factor: cytotoxic or necrotizing activity and its mechanism.
Haranaka K; Satomi N; Sakurai A; Haranaka R
Ciba Found Symp; 1987; 131():140-53. PubMed ID: 3450479
[TBL] [Abstract][Full Text] [Related]
2. Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity.
van de Wiel PA; van der Pijl A; Bloksma N
Cancer Immunol Immunother; 1991; 33(2):115-20. PubMed ID: 2036659
[TBL] [Abstract][Full Text] [Related]
3. Possible relationships between in vivo antitumour activity and toxicity of tumour necrosis factor-alpha.
Palladino MA; Patton JS; Figari IS; Shalaby MR
Ciba Found Symp; 1987; 131():21-38. PubMed ID: 3330012
[TBL] [Abstract][Full Text] [Related]
4. [Antitumor activity of tumor necrosis factor (TNF) in vitro and in vivo].
Haranaka K; Satomi N; Sakurai A
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1387-93. PubMed ID: 6742865
[TBL] [Abstract][Full Text] [Related]
5. Synergistic cytotoxic and antitumor effects of recombinant human tumor necrosis factor and hyperthermia.
Watanabe N; Niitsu Y; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Feb; 48(3):650-3. PubMed ID: 3335027
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice.
Haranaka K; Satomi N; Sakurai A
Int J Cancer; 1984 Aug; 34(2):263-7. PubMed ID: 6469400
[TBL] [Abstract][Full Text] [Related]
7. Lack of antitumour activity of human recombinant tumour necrosis factor-alpha, alone or in combination with melphalan in a nude mouse human melanoma xenograft system.
Furrer M; Altermatt HJ; Ris HB; Althaus U; Rüegg C; Liénard D; Lejeune FJ
Melanoma Res; 1997 Aug; 7 Suppl 2():S43-9. PubMed ID: 9578416
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of recombinant human tumor necrosis factor and hyperthermia on in vitro cytotoxicity and artificial metastasis.
Niitsu Y; Watanabe N; Umeno H; Sone H; Neda H; Yamauchi N; Maeda M; Urushizaki I
Cancer Res; 1988 Feb; 48(3):654-7. PubMed ID: 2825981
[TBL] [Abstract][Full Text] [Related]
9. Step-down heating enhances the cytotoxicity of human tumour necrosis factor on murine and human tumour cell lines in vitro.
Klostergaard J; Akimaru Y; Tomasovic SP
Int J Hyperthermia; 1996; 12(1):97-114. PubMed ID: 8676012
[TBL] [Abstract][Full Text] [Related]
10. [Definition of tumor-necrosis factor and its production mechanism].
Urushizaki I; Niitsu Y; Watanabe N
Gan To Kagaku Ryoho; 1984 Jul; 11(7):1356-68. PubMed ID: 6378100
[TBL] [Abstract][Full Text] [Related]
11. Changes in endogenous cytokines, adhesion molecules and platelets during cytokine-induced tumour necrosis.
de Kossodo S; Moore R; Gschmeissner S; East N; Upton C; Balkwill FR
Br J Cancer; 1995 Nov; 72(5):1165-72. PubMed ID: 7577463
[TBL] [Abstract][Full Text] [Related]
12. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
Lin JC; Park HJ; Song CW
Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
[TBL] [Abstract][Full Text] [Related]
13. Relationship of tumour necrosis factor and endotoxin to macrophage cytotoxicity, haemorrhagic necrosis and lethal shock.
Rothstein JL; Schreiber H
Ciba Found Symp; 1987; 131():124-39. PubMed ID: 3330008
[TBL] [Abstract][Full Text] [Related]
14. Augmented antitumour effects of combined treatment with hyperthermia and tumour necrosis factor on human gastric cancer xenotransplanted into nude mice.
Fujimoto S; Konno C; Kobayashi K; Kokubun M; Shrestha RD; Kiuchi S; Takahashi M; Ohta M; Okui K
Int J Hyperthermia; 1991; 7(3):511-8. PubMed ID: 1919146
[TBL] [Abstract][Full Text] [Related]
15. Human TNF mutants with selective activity on the p55 receptor.
Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W
Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906
[TBL] [Abstract][Full Text] [Related]
16. Augmentation of the generation of cytotoxic T lymphocytes against syngeneic tumor cells by recombinant human tumor necrosis factor.
Nakano K; Okugawa K; Furuichi H; Matsui Y; Sohmura Y
Cell Immunol; 1989 Apr; 120(1):154-64. PubMed ID: 2649256
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of blood stasis and vascular permeability in Meth-A tumors by administration of hyperthermia in combination with tumor necrosis factor.
Umeno H; Watanabe N; Yamauchi N; Tsuji N; Okamoto T; Niitsu Y
Jpn J Cancer Res; 1994 Mar; 85(3):325-30. PubMed ID: 8188532
[TBL] [Abstract][Full Text] [Related]
18. Structure-function relationship of tumour necrosis factor and its mechanism of action.
Fiers W; Brouckaert P; Goldberg AL; Kettelhut I; Suffys P; Tavernier J; Vanhaesebroeck B; Van Roy F
Ciba Found Symp; 1987; 131():109-23. PubMed ID: 3131072
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor effect of recombinant human tumor necrosis factor in combination with recombinant human granulocyte colony-stimulating factor in BALB/c mice.
Maeda M; Watanabe N; Tsuji N; Tsuji Y; Okamoto T; Sasaki H; Akiyama S; Niitsu Y
Jpn J Cancer Res; 1993 Aug; 84(8):921-7. PubMed ID: 7691787
[TBL] [Abstract][Full Text] [Related]
20. Effects of intraperitoneal recombinant interleukin-1 beta in intraperitoneal human ovarian cancer xenograft models: comparison with the effects of tumour necrosis factor.
Malik ST; East N; Boraschi D; Balkwill FR
Br J Cancer; 1992 May; 65(5):661-6. PubMed ID: 1586593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
